| Literature DB >> 36192764 |
Martin Silverborn1,2, Leon Arnar Heitmann3,4, Nanna Sveinsdottir3,4, Sigurjon Rögnvaldsson3, Tomas Thor Kristjansson3, Tomas Gudbjartsson3,4.
Abstract
INTRODUCTION: Non-infectious sternal dehiscence (NISD) is a known complication following coronary artery bypass grafting (CABG), with previous studies estimating an incidence of 0.4-1% of surgeries. We aimed to study the incidence of NISD together with short- and long-term outcomes in a whole-nation cohort of patients.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36192764 PMCID: PMC9528060 DOI: 10.1186/s13019-022-02015-1
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.522
Fig. 1A flowchart showing patient inclusion for the present study
Fig. 2Incidence of non-infectious sternal dehiscence as a proportion of annual CABG procedures. The incidence did not change significantly over the study period
Fig. 3A cumulative Kaplan–Meier graph depicting the time to diagnosis of non-infectious sternal dehiscence
Patient demographics and operative parameters in both groups
| Variables | Intact sternum | NISD | p value |
|---|---|---|---|
| Age, years (Mean, SD) | 67 (9.3) | 72 (8.9) | 0.02 |
| Female | 394 (17.4) | 4 (20.0) | 0.99 |
| BMI, kg/m2 | 27.8 [25.4, 30.9] | 31.4 [28.0, 34.6] | 0.004 |
| History of Smoking | 1555 (68.9) | 16 (80.0) | 0.40 |
| Hypertension | 1483 (65.9) | 15 (75.0) | 0.54 |
| Diabetes | 411 (18.3) | 7 (35.0) | 0.10 |
| Hyperlipidemia | 1224 (55.6) | 9 (45.0) | 0.47 |
| COPD | 162 (7.2) | 5 (25.0) | 0.009 |
| History of MI | 546 (24.2) | 12 (60.0) | 0.001 |
| History of cardiac arrhythmia | 258 (11.4) | 1 (5.0) | 0.58 |
| Heart failure | 184 (8.1) | 4 (20.0) | 0.13 |
| Valvular disease | 82 (3.6) | 1 (5.0) | 1.0 |
| Previous PCI | 533 (23.6) | 6 (30.0) | 0.69 |
| Hemoglobin, g/L | 142 [132, 151] | 143 [136, 147] | 0.99 |
| eGFR, ml/min/1.73m2 | 76.4 (20.4) | 69.8 (19.8) | 0.15 |
| EuroSCORE II | 1.4 [0.9, 2.5] | 2.5 [1.3, 5.6] | 0.009 |
| CSS class 4 | 907 (40.1) | 13 (65.0) | 0.04 |
| NYHA class IV | 385 (17.0) | 7 (35.0) | 0.07 |
| LVEF, % | 55 [50, 60] | 50 [40, 55] | 0.001 |
| 3-vessel disease | 2018 (89.3) | 20 (100.0) | 0.24 |
| Left main stem disease | 944 (41.8) | 8 (40.0) | 1.0 |
| Off-pump CABG | 401 (17.7) | 3 (15.0) | 0.98 |
| Acute or semi-acute surgery | 1238 (54.8) | 11 (55.0) | 0.99 |
| ECC time, min | 87 [71, 107] | 90 [77, 98] | 0.93 |
| Cross-clamp time, min | 46 [37, 58] | 42 [37, 49] | 0.09 |
| LIMA-graft used | 2134 (94.5) | 18 (90.0) | 0.70 |
| Number of distal anastomoses | 3.4 (0.9) | 3.6 (0.8) | 0.44 |
| IABP used intra- or postoperatively | 96 (4.2) | 4 (20.0) | 0.004 |
Number (%) or means with standard deviation
Values are presented as count (%) or median [IQR] unless specified otherwise
BMI body mass index; eGFR; estimated glomerular filtration rate; CSS Canadian Cardiovascular Society; NYHA New York Heart Association; COPD chronic obstructive pulmonary disease; MI myocardial infarction; PCI percutaneous coronary intervention; ECC extracorporeal circulation; LIMA left internal mammary artery; IABP intra-aortic balloon pump
Comparison of postoperative bleeding, blood products administrated, and the length of stay
| Post op variables | Intact sternum | NISD | p value |
|---|---|---|---|
| Chest tube output within 24 h., mL | 730 [520, 1040] | 623 [458, 1036] | 0.43 |
| Packed red cells administered, units | 1 [0, 3] | 2 [1, 8] | 0.02 |
| Length of ICU stay, days | 1 [1] | 2 [1, 5] | < 0.001 |
| Total length of stay, days | 8 [7, 11] | 21 [17, 28] | < 0.001 |
Values are presented as median [IQR] unless specified otherwise.
ICU intensive care unit
Comparison of minor and major early postoperative complications between groups
| Intact sternum | NISD | p value | |
|---|---|---|---|
| New onset atrial fibrillation | 857 (37.9) | 11 (55.0) | 0.18 |
| Pleural effusion requiring drainage | 287 (12.7) | 4 (20.0) | 0.52 |
| Pneumonia | 146 (6.5) | 5 (25.0) | 0.004 |
| Urinary tract infection | 71 (3.1) | 2 (10.0) | 0.27 |
| Superficial infection of leg after vein harvesting | 221 (9.8) | 6 (30.0) | 0.006 |
| Re-exploration for bleeding | 114 (5.0) | 2 (10.0) | 0.62 |
| Perioperative stroke | 25 (1.1) | 0 (0) | 1.0 |
| Multiorgan failure | 62 (2.7) | 2 (10.0) | 0.19 |
| Perioperative MI | 91 (4.0) | 1 (5.0) | 1.0 |
| 30 day mortality | 52 (2.3) | 1 (5.0) | 0.96 |
Values are presented as count (%) unless specified otherwise.
MI myocardial infarction
Fig. 4A Kaplan–Meier graph depicting the estimated overall survival with 95% confidence intervals (shades) of patients with non-infectious sternal dehiscence versus non-dehiscence